Evaluation of Investigational (Frequent Replacement) FRP Lens for Daily Wear
Public ClinicalTrials.gov record NCT02362724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the CooperVision, Inc. Sapphire and Pearl Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear.
Study identification
- NCT ID
- NCT02362724
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- CooperVision, Inc.
- Industry
- Enrollment
- 89 participants
Conditions and interventions
Conditions
Interventions
- Sapphire Device
- Pearl Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- May 31, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Oct 13, 2020
2015
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Eric M White OD, Inc. | San Diego | California | 92123 | — |
| Office of Mark E Nakano, O.D. | Torrance | California | 90503 | — |
| Advanced Family Eye Care | Denver | North Carolina | 28037 | — |
| Quinn Foster & Associates | Athens | Ohio | 45701 | — |
| Primary Eyecare Group, P.C. | Brentwood | Tennessee | 37027 | — |
| Premier Vision Services, LLC | Amarillo | Texas | 79119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02362724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02362724 live on ClinicalTrials.gov.